Table 3.

Association between CLS-B and subsequent cancer risk

BBD controls n = 86BBD cases n = 86PaPbPc
Any CLS-B, n (%)16 (18.6%)21 (24.4%)0.070.090.11
>5 CLS-B, n (%)4 (4.7%)9 (10.5%)0.0070.010.02
Number of CLS-B (among CLS-B–positive samples)
 Median (range)3 (1–55)5 (1–37)0.810.800.84
CLS-B densityd (among CLS-B–positive samples)
 Median (range)2.7 (0.7–19.7)3.3 (0.7–27.0)0.740.330.42
MSS, n (%)0.540.730.93
 125 (29.1%)30 (34.9%)
 237 (43.0%)33 (38.4%)
 324 (27.9%)23 (26.7%)
 Mean (SD)1.99 (0.76)1.92 (0.79)
  • aP value from conditional logistic regression, adjusted for adipose area (cm2) for measures not standardized to area.

  • bP value from conditional logistic regression adjusting for adipose area (cm2) as above and also histologic impression.

  • cP value from conditional logistic regression adjusting for adipose area (cm2) as above and also histologic impression and BMI.

  • dLesions/cm2 adipose tissue